Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy
Melissa N. HinmaniD, Jared I. Richardson, Rose A. Sockol, Eliza D Aronson, Sarah J. StednitziD, Katrina N. Murray, J. Andrew BerglundiD, Karen J. GuilleminiD
Abstract
The muscleblind RNA binding proteins (MBNL1, MBNL2, and MBNL3) are highly conserved across vertebrates and are important regulators of RNA alternative splicing. Loss of MBNL protein function through sequestration by CUG or CCUG RNA repeats is largely responsible for the phenotypes of the human genetic disorder myotonic dystrophy (DM). We generated the first stable zebrafish (Danio rerio) models of DM-associated MBNL loss of function through mutation of the three zebrafish mbnl genes. In contrast to mouse models, zebrafish double and triple homozygous mbnl mutants were viable to adulthood. Zebrafish mbnl mutants displayed disease-relevant physical phenotypes including decreased body size and impaired movement. They also exhibited widespread alternative splicing changes, including the misregulation of many DM-relevant exons. Physical and molecular phenotypes were more severe in compound mbnl mutants than in single mbnl mutants, suggesting partially redundant functions of Mbnl proteins. The high fecundity and larval optical transparency of this complete series of zebrafish mbnl mutants will make them useful for studying DM-related phenotypes and how individual Mbnl proteins contribute to them, and for testing potential therapeutics.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 15
- FWCI
- 0.86
- Field percentile
- top 31%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Muscleblind-like proteins dimerize by forming disulfide bonds to regulate alternative splicing and pathogenic RNA foci formation
Luke A. Knudson, Adam Kosti, … Gary Jonathan Bassell·Nucleic Acids ResearchPeer-reviewed·May 20, 2026
- Loss of Muscleblind Splicing Factor Shortens C. elegans Lifespan by Reducing the Activity of p38 MAPK/PMK-1 and Transcription Factors ATF-7 and Nrf/SKN-1
Olli Matilainen, Ana Rita Salgado Ribeiro, … Susana M. D. A. Garcia·GeneticsPeer-reviewed·Jul 22, 2021
- Alternative splicing of SORBS1 affects neuromuscular junction formation and stability in myotonic dystrophy type 1
Caroline Hermitte, Hortense de Calbiac, … Morgan Gazzola·bioRxiv·Dec 23, 2024
- An in vivo approach to characterize novel variants associated with musculoskeletal disorders
Jennifer F. McAdow, Shuo Yang, … Aaron N. Johnson·JCI InsightPeer-reviewed·May 17, 2022
- Elimination of myotonia improves myopathy in a muscleblind knockout model of myotonic dystrophy
Matthew T. Sipple, Sakura A. Hamazaki, … John D. Lueck·bioRxiv·Sep 19, 2025
- Co-opting MBNL-dependent alternative splicing cassette exons to control gene therapy in myotonic dystrophy
Samuel Carrell, Ellie M. Carrell, … Beverly L. Davidson·Annals of NeurologyPeer-reviewed·Aug 29, 2025